>> 全站文章索引 >> 第17页:
  • Assessing the clinical utility of agoraphobia in the context of panic disorder - [Schmidt NB, Cromer KR.]
  • The effect of paroxetine on 5-HT(2A) receptors in depression: An [18F]setoperone PET imaging study - [Jeffrey H Meyer, Shitij Kapur, Beata Eisfeld, Gregory M Brown, et al]
  • Treatment ofdepressionin patients with breast cancer:a comparison between paroxetine and amitriptyline - [G. Pezzella, R. Moslinger-Gehmayr, A. Contu]
  • Treatment of bereavement-related depression and traumatic grief - [Paula L. Hensley]
  • HIV-assoziierte Tumore - [A. Potthoff1 und N. H. Brockmeyer]
  • Affective symptoms and cognitive functions in the acute phase of Graves’ thyrotoxicosis - [Vogel A, Elberling TV, H?rding M, Dock J, Rasmussen AK, Feldt-Rasmussen U, Perrild H, Waldemar G.]
  • Separation-induced ultrasonic vocalization in rat pups: Further pharmacological characterization - [Michihiko Iijima and Shigeyuki Chaki]
  • The Effect of Tryptophan on Social Interaction in Everyday Life: A Placebo-Controlled Study - [DS Moskowitz1 Ph.D, Gilbert Pinard2 MD, David C Zuroff1 Ph.D, Lawrence Annable2 BSc, Dip Stat and Simon N Young2 Ph.D]
  • Digitalis intoxication induced by paroxetine co-administration - [Norio Yasui-Furukori, Sunao Kaneko]
  • Blood–brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls - [Manfred Uhr, Markus T. Grauer, Alexander Yassouridis and Martin Ebinger]
  • First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression - [F Konig, C v Hippel, T Petersdorff, M Neuhoffer-Weiss, et al.]
  • Pharmacogenetics and adverse drug reactions - [Urs A Meyer]
  • Review of 1H magnetic resonance spectroscopy findings in major depressive disorder-A meta-analysis - [Yildiz-Yesiloglu A, Ankerst DP.]
  • Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment - [E. Poulet, J. Brunelin, C. Boeuve, J. Lerond, T. D'Amato, J. Dalery and M. Saoud]
  • Low density and high affinity of platelet [3H]paroxetine binding in women with bulimia nervosa - [Agneta Ekman, Charlotta Sundblad-Elverfors, Mikael Landén, Tomas Eriksson and Elias Eriksson]
  • Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients - [F Graziano1, R Bisonni2, V Catalano3, R Silva2, S Rovidati4, E Mencarini4, B Ferraro4, F Canestrari4, A M Baldelli3, A De Gaetano5, P Giordani3, E Testa1 and V Lai1]
  • Questions about SSRI antidepressant drug regulation - [Alastair Hay]
  • The Relevance of Pharmacokinetic Studies in Designing Efficacy Trials in Juvenile Major Depression - [Robert L. Findling, Nora K. McNamara, Robert J. Stansbrey, Norah C. Feeny, Christopher M. Young, Franco V. Peric, Eric A. Youngstrom]
  • Difficult people getting along - [Larry Greenbaum]
  • Regarding Pooh / The authors respond / Editors' note - [Julie Downs, Leslie Blumenberg, JoAnn Schuh, Stephen Black, et al]
  • Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze - [Venessa Beijamini and Roberto Andreatini]
  • Inhibition of vesicular uptake of monoamines by hyperforin - [Netta Roz, Yehuda Mazur, Amiram Hirshfeld and Moshe Rehavi]
  • Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteers - [Ellen R.A. de Bruijn, Bernard G.C. Sabbe, Wouter Hulstijn, Gé S.F. Ruigt and Robbert J. Verkes]
  • The immune system and happiness - [Barak Y.]
  • How nurses in a stroke rehabilitation unit attempt to meet the psychological needs of patients who become depressed following a stroke - [Bennett, Beverley B.]
  • New approaches in managing bipolar depression - [Keck PE, McElroy SL]
  • The physiological and pathophysiological roles of neuronal histamine - [Yanai K, Tashiro M.]
  • Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: Evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors - [Cheryl L. Barton, Peter H. Hutson * Merck Sharp and Dohme, Neuroscience Research Centre, Terlings Park, Harlow Essex, U.K.]
  • Anxiolytic-Like Effects of Antidepressants After Acute Administration in a Four-Plate Test in Mice - [Martine Hasco?t, Michel Bourin, Marie Claude Colombel, Alexandra J. Fiocco and Glen B. Baker]
  • Cell Proliferation is Influenced by Bulbectomy and Normalized by Imipramine Treatment in a Region-Specific Manner - [Gerburg Keilhoff1, Axel Becker2, Gisela Grecksch2, Hans-Gert Bernstein3 and Gerald Wolf1]
  • Fox odour affects corticosterone release but not hippocampal serotonin reuptake and open field behaviour in rats - [Danusa Dias Soares, Francesca Fernandez, Sylvie Aguerre, Aline Foury, Pierre Mormède and Francis Chaouloff]
  • Concise synthesis of trans- and cis-3,4-disubstituted piperidines based on regio- and stereoselective allylation of cyclopentenyl esters - [Junji Igarashi, Hiroyuki Ishiwata and Yuichi Kobayashi]
  • Critical Prenatal and Postnatal Periods for Persistent Effects of Dexamethasone on Serotonergic and Dopaminergic Systems - [Theodore A Slotkin1, Marisa L Kreider1, Charlotte A Tate1 and Frederic J Seidler1]
  • Have drug companies hyped social anxiety disorder to increase sales? - [David Healy, David V Sheehan]
  • Warnings Added to Two Antidepressants - [Anonymous]
  • Evaluating the tolerability of newer antidepressants - [Dewan MJ, Anand VS.]
  • Evaluating the Tolerability of the Newer Antidepressants - [Dewan MJ, Anand VS.]
  • Centrally active nonhormonal hot flash therapies - [Loprinzi CL, Stearns V, Barton D.]
  • Centrally active nonhormonal hot flash therapies - [Charles Loprinzi and Vered Stearns]
  • Effects of Standardized Extracts of St. John’s Wort on the Single-Unit Activity of Serotonergic Dorsal Raphe Neurons in Awake Cats: Comparisons with Fluoxetine and Sertraline - [Steven T Szabo1 BSc and Pierre Blier2 MD, Ph.D]
  • In Vivo Measurement of the Vesicular Monoamine Transporter in Schizophrenia - [Stephan F Taylor1 MD, Robert A Koeppe2 Ph.D, Rajiv Tandon1 MD, Jon-Kar Zubieta1,4 MD, Ph.D and Kirk A Frey2,3,4 MD, Ph.D]
  • Etiologic Factors of Chronic Constipation—Review of the Scientific Evidence - [Leung FW]
  • A quantitative genomic expression analysis platform for multiplexed in vitro prediction of drug action - [E C Gunther1, D J Stone1,2, J M Rothberg1 and R W Gerwien1]
  • Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response - [J Kirchheiner1, K Nickchen1, M Bauer2, M-L Wong3, J Licinio3, I Roots1 and J Brockm?ller4]
  • Long term therapy of generalized anxiety disorder - [Frédéric Rouillon]
  • Gender related disabilities in panic disorder - [G. Sachs, M. Amering, P. Berger, H. Katschnig]
  • Are gender differences important for the clinical effects of antidepressants? - [Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P, The Danish University Antidepressant Group]
  • Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms - [Moretti R, Torre P, Antonello RM, Cazzato G, Bava A]
  • Neonatal paroxetine withdrawal syndrome. - [Stiskal JA, Kulin N, Koren G, Ho T, Ito S]
  • Role of Norepinephrine in the Pathophysiology and the treatment of mood disorders - [Ressler KJ, Nemeroff CB.]
  • Medicaid Coverage of Newer Psychotropic Medication - [Meenakshi Venkataraman]
  • Targets for the Development of Novel Therapeutics for Bipolar Disorder - [Zarate CA, Singh J, Manji HK.]
  • Intent-to-treat analysis for clinical trials: use of data collected after termination of treatment protocol - [Sati Mazumdar, Patricia R. Houck, Kenneth S. Liu, Benoit H. Mulsant, Bruce G. Pol1ock, Mary Amanda Dew and Charles F. Reynolds III]
  • Posttraumatic stress disorder acquisition, recognition, course, and treatment - [Davidson JR, Stein DJ, Shalev AY, Yehuda R.]
  • Posttraumatic stress disorder: acquisition, recognition, course, and treatment. - [Davidson JR, Stein DJ, Shalev AY, Yehuda R]
  • Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography–electrospray ionization mass spectrometry (HPLC–MS/ESI) - [He Juan, Zhou Zhiling and Li Huande]
  • A Review of its Therapeutic Potential in the Treatment of Depression Associated with Physical Illness - [Cheer SM, Goa KL.]
  • Reduced Density of Platelet-Binding Sites for [3H]Paroxetine in Remitted Bulimic Women - [Howard Steiger1,2,3, Jodie Richardson1,2, Mimi Israel1,2,3, N M K Ng Ying Kin2,3, Kenneth Bruce1,2,3, Sandra Mansour1,2 and Anne Marie Parent1,2]
  • A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment - [J Kirchheiner1, K Nickchen2, J Sasse3, M Bauer3, I Roots2 and J Brockm?ller4]
  • Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes? - [Linda Franchini, David Rossini, Fanny Bongiorno, Chiara Spagnolo, Enrico Smeraldi and Raffaella Zanardi]
  • Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction - [H G Nurnberg1, M Fava2, A J Gelenberg3, P L Hensley1 and S Paine1]
  • Changes in Human In vivo Serotonin and Dopamine Transporter Availabilities during Chronic Antidepressant Administration - [Akira Kugaya, Nicholas M Seneca, Peter J Snyder, Stephen A Williams, Robert T Malison, Ronald M Baldwin, John P]
  • The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test - [H. R. Sumnall, E. O'Shea, C. A. Marsden and J. C. Cole]
  • Changes in anxiety sensitivity with pharmacotherapy for panic disorder - [Naomi M. Simon, Michael W. Otto, Jasper A. J. Smits, D. Colette Nicolaou, Hannah E. Reese and Mark H. Pollack]
  • Fatigue and cancer: causes, prevalence and treatment approaches - [L I Wagner1 and D Cella1]
  • Revamping the Pharmaceutical Industry in Light of GlaxoSmithKline's Settlement - [Benjamin Falit]
  • USE OF HEALTH SERVICES FOR MAJOR DEPRESSIVE AND ANXIETY DISORDERS IN FINLAND - [H?m?l?inen J, Isomets? E, Sihvo S, Pirkola S, Kiviruusu O]
  • USE OF HEALTH SERVICES FOR MAJOR DEPRESSIVE AND ANXIETY DISORDERS IN FINLAND - [H?m?l?inen J, Isomets? E, Sihvo S, Pirkola S, Kiviruusu O.]
  • Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics - [Martin A. Javors, Chamindi Seneviratne, John D. Roache, Nassima Ait-Daoud, Susan E. Bergeson, M. Consuelo Walss-Bass, Fatema Z. Akhtar and Bankole A. Johnson]
  • Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells - [Lynn W. Maines, David A. Antonetti, Ellen B. Wolpert and Charles D. Smith]
  • Enantioselective total and formal syntheses of paroxetine (PAXIL) via phosphine-catalyzed enone α-arylation using arylbismuth(V) reagents: a regiochemical complement to Heck arylation - [Phillip K. Koech and Michael J. Krische]
  • Neurosteroid secretion in panic disorder - [Francesca Brambilla, Giovanni Biggio, Maria Giuseppina Pisu, Laura Bellodi, Giampaolo Perna, Vesna Bogdanovich-Djukic, Robert H. Purdy and Mariangela Serra]
  • Duloxetine Increases Serotonin and Norepinephrine Availability in Healthy Subjects: A Double-Blind, Controlled Study - [Stephan A Chalon1, Luc-André Granier1, Fran?ois R Vandenhende1, Peter R Bieck2, Frank P Bymaster2, Melissa J Joliat2, Christine Hirth3 and William Z Potter2]
  • Inflamed brains can trigger the blues, studies suggest - [Gunjan Sinha]
  • L-DOPA Disrupts Activity in the Nucleus Accumbens during Reversal Learning in Parkinson's Disease - [Roshan Cools1, Simon J G Lewis1, Luke Clark1, Roger A Barker2 and Trevor W Robbins1]
  • Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular 5-HT in the frontal cortex of freely moving rats - [Jenny C E Owen, Peter S Whitton]
  • Ageing and neuronal vulnerability - [Mattson MP, Magnus T.]
  • Rational Antidepressant Selection：Applying Evidence-Based Medicineto Complex Real-World Patients - [Zetin M, Hoepner CT, Bjornson L]
  • Rational Antidepressant Selection-Applying Evidence-Based Medicine to Complex Real-World Patients - [Zetin M, Hoepner CT, Bjornson L.]
  • Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine - [Vered Stearns, Michael D. Johnson, James M. Rae, Alan Morocho, Antonella Novielli, Pankaj Bhargava, Daniel F. Hayes,]
  • Relationship of Mania Symptomatology to Maintenance Treatment Response with Divalproex, Lithium, or Placebo - [Charles L Bowden1, Michelle A Collins2, Susan L McElroy3, Joseph R Calabrese4, Alan C Swann5, Richard H Weisler6,7 and Patricia J Wozniak2]
  • Aging, estradiol and time of day differentially affect serotonin transporter binding in the central nervous system of female rats - [Kristine Krajnak, Katherine L. Rosewell, Marilyn J. Duncan and Phyllis M. Wise]
  • Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety - [Sandy Hogg, Line Michan and Maria Jessa]
  • Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. - [Kennedy SH, Andersen HF, Lam RW]
  • Acute SSRI Administration Affects the Processing of Social Cues in Healthy Volunteers - [C J Harmer1, Z Bhagwagar1, D I Perrett2, B A V?llm1, P J Cowen1 and G M Goodwin1]
  • Rapid response of emotional incontinence to selective serotonin reuptake inhibitors - [Nahas Z, Arlinghaus KA, Kotrla KJ, Clearman RR, George MS]
  • Electroanalytical determination of paroxetine in pharmaceuticals - [Henri P.A. Nouws, Cristina Delerue-Matos, Aquiles A. Barros and José A. Rodrigues]
  • The effects of antidepressants on obstructed and unobstructed gait in healthy elderly people - [Louis F Draganich, James Zacny, Jerome Klafta, Theodore Karrison]
  • Accelerating response in geriatric depression: A pilot study combining sleep deprivation and paroxetine - [Gregory M. Bump, M.S. 1, Charles F. Reynolds III, M.D. 1 *, Gwenn Smith, Ph.D. 1, Bruce G. Pollock, M.D., Ph.D. 1, Mary Amanda Dew, Ph.D. 1, Sati Mazumdar, Ph.D. 1, Matthew Geary, B.A. 1, Patricia R. Houck, M.S.H. 1, David J. Kupfer, M.D. 2 AD:1Mental Hea]
  • Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly - [Gregory M. Bump, M.D., Benoit H. Mulsant, M.D., Bruce G. Pollock, M.D., Ph.D., Sati Mazumdar, Ph.D., Amy E. Begley, M.A., Mary Amanda Dew, Ph.D., Charles F. Reynolds III, M.D. * AD:Intervention Research Center for Late-Life Mood Disorders, Department of P]
  • A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes - [Paola Rocca, Livio Marchiaro, Roberta Rasetti, Elisa Rivoira and Filippo Bogetto]
  • Predictors of nonresponse to treatment in primary care patients with dysthymia - [Wayne Katon, Joan Russo, Ellen Frank, James Barrett, John W. Williams, Thomas Oxman, Mark Sullivan and John Cornell]
  • Respiratory irregularity and stress hormones in panic disorder exploring potential linkages - [Abelson JL, Khan S, Lyubkin M, Giardino N.]
  • Respiratory irregularity and stress hormones in panic disorder exploring potential linkages - [Abelson JL, Khan S, Lyubkin M, Giardino N.]
  • Depression after stroke - [Castillo, Carlos S.; Robinson, Robert G.]
  • Therapeutic potential of RNA interference for neurological disorders - [Sah DW.]
  • Assessment of the Serotonin and Norepinephrine Reuptake Blocking Properties of Duloxetine in Healthy Subjects - [Julie E Turcotte MD, Guy Debonnel MD, Claude de Montigny MD, Ph.D, Chantal Hébert RN and Pierre Blier MD, Ph.D]
  • Double-blind placebo-controlled pilot study of paroxetine for specific phobia - [J. Benjamin, I. Z. Ben-Zion, E. Karbofsky, P. Dannon]
  • THE RISE AND RISE OF DRUG DELIVERY - [Howard Rosen & Thierry Abribat about the authors]
  • Withdrawal from paroxetine can be severe, warns FDA - [Alison Tonks]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 [17] 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50